Filter Results:
(5,268)
Show Results For
- All HBS Web
(5,268)
- People (17)
- News (2,113)
- Research (2,467)
- Events (3)
- Multimedia (221)
- Faculty Publications (1,886)
Show Results For
- All HBS Web
(5,268)
- People (17)
- News (2,113)
- Research (2,467)
- Events (3)
- Multimedia (221)
- Faculty Publications (1,886)
- March 2016 (Revised March 2022)
- Teaching Note
Express Scripts: Promoting Prescription Drug Home Delivery (A) and (B)
By: John Beshears
The pharmacy benefit manager (PBM) sector processes prescription drug claims on behalf of companies that offer a prescription drug benefit to their employees. The case associated with this teaching note follows Bob Nease, chief scientist at Express Scripts, as he... View Details
Keywords: Pharmaceuticals; Prescription Drugs; Pharmacy Benefit Manager; PBM; Healthcare; Behavioral Economics; Choice Architecture; Active Choice; Service Delivery; Decision Choices and Conditions; Consumer Behavior; Distribution Channels; Health Care and Treatment; Service Industry; Pharmaceutical Industry
- 01 Apr 2015
- Research & Ideas
The Slow, Steady Battle to Fix Cancer Care
payment model undoubtedly simplifies billing matters for the patients, the main impetus is to lower health care costs while simultaneously improving quality of care. In the traditional fee-for-service model,... View Details
- March 2015 (Revised January 2024)
- Case
CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies
By: Regina E. Herzlinger and Andrew Otazo
Duke Rohlen (HBS MBA ’01) hoped to win over a prominent venture capital investor for Series B financing of his firm CVI that was creating a drug-eluting balloon (DES) to treat peripheral arterial disease. As a second-mover, Duke felt he was more likely to acquire... View Details
Keywords: CV Ingenuity; CVI; Drug Eluting Balloon; DEB; Drug Eluting Stent; Angioplasty Balloon; FoxHollow; Medical Device; Medical Device Startup; Premarket Approval; PMA; Lutonix; Stellarex; LEVANT; ILLUMENATE; Clinical Trials; Peripheral Arterial Disease; PAD; Healthcare Startups; Covidien; Health Care and Treatment; Health Testing and Trials; Business Startups; Commercialization; Health Industry; Health Industry; United States; Europe
Herzlinger, Regina E., and Andrew Otazo. "CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies." Harvard Business School Case 315-045, March 2015. (Revised January 2024.)
Building A Culture of Health
This ambitious volume sets out to understand how every company impacts public health and introduces a robust model, rooted in organizational and scientific knowledge, for companies committed to making positive contributions to health and wellness. Focusing on four... View Details
- Web
The Caring Company
refuse to acknowledge it Ruth Reader 16 Jan 2019 | Fast Company The Caring Company Joseph Fuller & Manjari Raman 16 Jan 2019 | American Enterprise Institute Employers Are Clueless When It Comes To Family Caregiving Howard Gleckman 16 Jan... View Details
- summer 1998
- Article
The Managerial Revolution in the U.S. Health Care Sector: Lessons from the U.S. Economy
Herzlinger, Regina E. "The Managerial Revolution in the U.S. Health Care Sector: Lessons from the U.S. Economy." Health Care Management Review 23, no. 3 (summer 1998): 19–29.
- 28 Nov 2006
- Other Presentation
Value-Based Competition in Health Care: Issues for Singapore
This presentation draws Michael E. Porter and Elizabeth Olmsted Teisberg: Redefining Health Care: Creating Value-Based Competition on Results, Harvard Business School Press, May 2006. Earlier publications about health care include the Harvard Business Review... View Details
Keywords: Integration; Competition; Customer Value and Value Chain; Insurance; Health Care and Treatment; Health Industry; Singapore
Porter, Michael E. "Value-Based Competition in Health Care: Issues for Singapore." Lee Kuan Yew School of Public Policy, Singapore, November 28, 2006.
- 2015
- Working Paper
How Should We Pay for Health Care?
By: Michael E. Porter and Robert S. Kaplan
Improving the way we pay for health care must be a central component in health care reform. Payment reform must link provider reimbursement and accountability to improving patient value: better health outcomes delivered at lower cost. Today’s deeply flawed... View Details
Porter, Michael E., and Robert S. Kaplan. "How Should We Pay for Health Care?" Harvard Business School Working Paper, No. 15-041, December 2014. (Revised February 2015.)
- July 2022
- Teaching Plan
Wellthy: The Economics of Caring
By: Brian Trelstad
Teaching Plan for HBS Case No. 320-028. In 2014, Lindsay Jurist-Rosner (MBA ’09) founded Wellthy, a B2C business that coordinates care for working professionals seeking help to support loved ones with chronic diseases or aging parents. With personal experience as a... View Details
- 20 Apr 2017
- Cold Call Podcast
Making Health Insurance That Consumers Actually Like
- July 2007 (Revised January 2008)
- Case
Turnaround at the Veterans Health Administration (A)
By: Amy C. Edmondson, Brian R. Golden and Gary J. Young
Investigates the challenges that Dr. Kenneth W. Kizer confronted in seeking to create organizational change at the largest integrated health care system in North America, the Veterans Health Administration (VHA). Kizer was appointed as the Under Secretary of Health, to... View Details
Keywords: Problems and Challenges; Organizational Change and Adaptation; Transformation; Leadership; Consolidation; Health Care and Treatment; Service Delivery; Health Industry; Health Industry; North and Central America
Edmondson, Amy C., Brian R. Golden, and Gary J. Young. "Turnaround at the Veterans Health Administration (A)." Harvard Business School Case 608-061, July 2007. (Revised January 2008.)
- September 1998 (Revised June 1999)
- Case
Discovery Health (A)
A South African health insurance company undertakes a redesign of its prescription drug coverage policy in light of its experiences with Prozac. View Details
Keywords: Motivation and Incentives; Service Delivery; Insurance; Health Care and Treatment; Insurance Industry; South Africa
Chun, Samuel S., and Shaun Matisson. "Discovery Health (A)." Harvard Business School Case 599-046, September 1998. (Revised June 1999.)
- 2015
- Case
Advanced Leadership Pathways: Mike Critelli and Dossia Service Corporation
By: Rosabeth Moss Kanter and Patricia Bissett Higgins
In 2010, Mark Critelli was a well-seasoned corporate executive who had recently transitioned from being the CEO of a Fortune 500 company to that of a startup called Dossia. As an AL Fellow, he knew that despite believing in Dossia’s mission to empower individuals with... View Details
Keywords: Health And Wellness; Health Care; Health Care Education; Health Care Entrepreneurship; Health Care Industry; Health Care Investment; Health Care Outcomes; Health Care Quality; Health Care Reform; Health Care Services; Health Costs; Preventive Care; Insurance Companies; Insurance Industry; Employee Compensation; Empoylee Wellness Programs; Patient Reported Outcome Measures; Patient Satisfaction; Data; Data Analytics; Entrepreneurs; Entrepreneurial Organizations; Entrepreneurial Ventures; Start-up; Leadership Skills; Disruptive Change; Health; Insurance; Employees; Leadership; Disruptive Innovation; Health Care and Treatment; Employment; Entrepreneurship; Business Startups; Information Technology; Analytics and Data Science; Health Industry; United States
Kanter, Rosabeth Moss, and Patricia Bissett Higgins. "Advanced Leadership Pathways: Mike Critelli and Dossia Service Corporation." Harvard Business Publishing Case 316-053, 2015. (Harvard Advanced Leadership Initiative.)
- 2014
- Other Unpublished Work
Nudging Physicians to Pursue Careers in Underserved Areas: A Case for Behavioral Economics
By: Joseph Lopez, Mona Singh, Nava Ashraf and Joel Weissman
Currently, more than 60 million Americans live in "Health Professional Shortage Areas." Unless policymakers can encourage more physicians to practice in medically under-resourced areas, an increased number of uninsured individuals newly able to obtain health insurance... View Details
- 20 Apr 2017
- News
Making Health Insurance That Consumers Actually Like
"Behavioral Hazard in Health Insurance"
A fundamental implication of standard moral hazard models is overuse of low-value medical care because copays are lower than costs. In these models, the demand curve alone can be used to make welfare statements, a fact relied on by much empirical work. There is... View Details
- 19 Oct 2018
- News
Lessons from Mayo Clinic’s Redesign of Stroke Care
- Article
Lessons from Mayo Clinic's Redesign of Stroke Care
By: Robert S. Kaplan, W. David Freeman, Kevin M. Barrett, Lisa Nordan, Aaron C. Spaulding and Meredith Karney
Facing escalating costs of medications and technology, health care patients and providers in the United States continue to search for opportunities to reduce overall costs while maintaining and improving health care outcomes. The Mayo Clinic Comprehensive Stroke Center... View Details
Kaplan, Robert S., W. David Freeman, Kevin M. Barrett, Lisa Nordan, Aaron C. Spaulding, and Meredith Karney. "Lessons from Mayo Clinic's Redesign of Stroke Care." Special Issue on HBR Insight Center: The Future of Health Care. Harvard Business Review (website) (October 2018).